Biomarker test could significantly reduce antibiotic use in sepsis, study finds
A major UK patient trial of a new biomarker testing protocol for sepsis has shown it is possible to safely...
News
-
More
-
MorePodiatry research is improving care for patients
Up to a tenth of people with diabetes will develop a diabetic foot ulcer at some point – and of...
-
MoreSalford Kidney Study plays key role in discovery of novel endotypes and biomarkers for diabetic kidney disease
MultiOmic Health, a leading AI-enabled drug discovery company, has announced the identification of novel patient endotypes and the development of...
-
MoreTaking part in research has been my chance to give something back, says Jean
“All through my life I’ve had care from the NHS, they have always been brilliant, and taking part in research...
-
MoreSalford primary school is the first in North West to take part in innovative diabetes screening research
Pupils at River View Primary School, Salford, are taking part in an innovative research study to identify those at risk...
-
MoreStronger and higher dose opioids linked to greater all-cause mortality risk
A new international study spanning the United Kingdom, United States, and Canada has revealed important insights into the risks associated...
-
More
Most non-cancer pain opioid prescriptions are for musculoskeletal conditions, study finds
Nearly three quarters of new non-cancer pain opioid prescriptions were for patients with musculoskeletal conditions, despite limited evidence of the...
-
MoreLeading the way on new treatment for meningioma
Brain tumour experts at Salford Royal have treated the first patient in the UK with a new investigational drug that...
-
MoreBlog: Apprenticeship helping Mark to develop research role
Mark Warburton is a Clinical Trials Administrator working with the Metabolic Medicine Research Team at Salford Care Organisation. Over the...
-
MoreWorld’s 1st human graphene-based brain computer interface procedure at Salford Royal
INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company pioneering graphene-based neural technologies, announced today the world’s first human procedure of...